Pharmacy
GSK announces Board changes
The FINANCIAL -- GSK on December 19 announced the creation of a new Board committee and a number of changes...
Biogen Names Michel Vounatsos Chief Executive Officer
The FINANCIAL -- Biogen on December 19 announced that its Board of Directors has appointed Michel Vounatsos as Chief Executive...
Novartis bolsters ophthalmology pipeline through acquisition of Encore Vision, Inc.
The FINANCIAL -- Novartis announced on December 20 that it has entered into a definitive agreement for the acquisition of...
Japan’s Ministry of Health, Labour and Welfare Approves Gilead’s Vemlidy for Patients With Chronic Hepatitis B Virus Infection
The FINANCIAL -- Gilead Sciences, Inc. on December 19 announced that the Japanese Ministry of Health, Labour and Welfare (MHLW)...
BASAGLAR (insulin glargine injection 100 units/mL), A Long-Acting Basal Insulin, Is Now Available in U.S.
The FINANCIAL -- Eli Lilly and Company and Boehringer Ingelheim Pharmaceuticals, Inc. announced on December 15 that BASAGLAR (insulin glargine...
Novartis bolsters innovative dermatology portfolio through acquisition of Ziarco Group Limited
The FINANCIAL -- Novartis announced on December 16 that it has entered into a definitive agreement for the acquisition of...
Sysmex, Astellas and Daiichi Sankyo Sign Memorandum of Understanding on the Creation of a Method for Analyzing Circulating Tumor Cells
The FINANCIAL -- Sysmex Corporation, Astellas Pharma Inc. and Daiichi Sankyo Co., Ltd. have signed a memorandum of understanding to...
Takeda Announces Sale of Shareholding in Wako Pure Chemical Industries, Ltd. to Fujifilm Corporation
The FINANCIAL -- Takeda Pharmaceutical Company Limited on December 15 held a meeting of the Board of Directors and adopted...
Pfizer and Astellas Announce Top-Line Results from Phase 4 PLATO Trial of XTANDI (enzalutamide) Capsules
The FINANCIAL -- Pfizer Inc. and Astellas Pharma Inc. on December 14 announced the Phase 4 PLATO study, evaluating the...
Bristol-Myers Squibb Strengthens Capabilities with Evolution of its U.S. Geographic Footprint
The FINANCIAL -- Bristol-Myers Squibb Company on December 20 announced important changes to its U.S. geographic footprint that will strengthen...
GSK opens new global vaccines R&D center in Rockville, MD, USA
The FINANCIAL -- GSK will inaugurate its newest global vaccines research and development (R&D) center in Rockville, Maryland, further strengthening...
Monsanto Shareowners Approve Merger with Bayer
The FINANCIAL -- Monsanto Company announced that at a special meeting of shareowners held on December 13, shareowners of the...
U.S. FDA approves Synjardy XR tablets for adults with type 2 diabetes
The FINANCIAL -- The U.S. Food and Drug Administration (FDA) has approved Synjardy XR (empagliflozin and metformin hydrochloride extended-release) tablets...
Astellas Announces Transfer of Qutenza to Grünenthal
The FINANCIAL -- Astellas Pharma Inc. on December 12 announced that Astellas Pharma Europe Ltd. has entered into a definitive...
Astrazeneca and Lilly to develop second potentially disease-modifying treatment for Alzheimer’s disease
The FINANCIAL -- AstraZeneca and Eli Lilly and Company on December 9 announced a worldwide agreement to co-develop MEDI1814, an...
ADVERTISEMENT
Popular Last 24h
-
What time is SpaceX’s Starship Flight 7 launch test on Jan. 13?
-
RFE/RL: Letter from Congress Urges U.S. Secretary of State Nominee Marco Rubio to Sanction Ivanishvili’s “Enablers”
-
Real Estate in Focus: 2025 Trends to Watch
-
IRS announces Jan. 27 start to 2025 tax filing season;
-
Austin metro ranks among highest wildfire risk in U.S., analysis shows
-
What were the most destructive wildfires in California’s history?
-
The world is getting hotter
LATEST POSTS
LATESTINTERVIEWS
ADVERTISEMENT
